Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
On Nov 13, MVC announced that it has won a 470 mil yuan (US$71.52 mil) clinical subsidy contract from the Taiwanese Central Disease Control (CDC).
It is the first company to receive the Taiwanese Government’s subsidies among the four domestic companies approved by the CDC to conduct human clinical trials.
